Company

NOBO Medicine, Inc.

NOBO Medicine develops biomarker-based therapeutics for oncology and chronic diseases.

About

Founded in 2017 and based in Seoul, South Korea, NOBO Medicine develops therapeutics using biomarker-driven precision medicine approaches. Its work targets oncology and chronic diseases and aims to identify patient groups for drug candidates. In June 2025, it raised KRW 5 billion in venture funding from STIC Ventures.

1Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in